Structure-Based Design of Xanthine-Benzimidazole ...ACS Publications
pubs.acs.org
von E Specker · · Zitiert von: 8 — This article is cited by 2 publications. Edgar Specker, Radoslaw Wesolowski, Anja Schütz, Susann Matthes, Keven Mallow, Malgorzata Wasinska von E Specker · · Zitiert von: 8 — This article is cited by 2 publications. Edgar Specker, Radoslaw Wesolowski, Anja Schütz, Susann Matthes, Keven Mallow, Malgorzata Wasinska- ...
Phenylalanine hydroxylase contributes to serotonin synthesis ...Wiley
faseb.onlinelibrary.wiley.com
von A Mordhorst · · Zitiert von: 15 — Susann Matthes,. Susann Matthes. Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany. Search for ... von A Mordhorst · · Zitiert von: 15 — Susann Matthes,. Susann Matthes. Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany. Search for ...
Structure-Based Design of Xanthine-Imidazopyridines andACS Publications
pubs.acs.org
von E Specker · · Zitiert von: 1 — Susann Matthes. Susann Matthes. Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC)von E Specker · · Zitiert von: 1 — Susann Matthes. Susann Matthes. Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC)
Peripheral Serotonin Synthesis as a New Drug TargetScienceDirect.com
www.sciencedirect.com
von S Matthes · · Zitiert von: 91 — Review. Peripheral Serotonin Synthesis as a New Drug Target. Author links open overlay panel. Susann Matthes 1 2 , Michael Bader Show more. von S Matthes · · Zitiert von: 91 — Review. Peripheral Serotonin Synthesis as a New Drug Target. Author links open overlay panel. Susann Matthes 1 2 , Michael Bader Show more.
Reevaluation of serotonin function with mice deficient in ...ScienceDirect.com
www.sciencedirect.com
von V Mosienko · · Zitiert von: 124 — Daniel Beis a , Massimo Pasqualetti b , Jonas Waider c , Susann Matthes a , Fatimunnisa Qadri a , Michael Bader a , Natalia Alenina a. Show more. Add to ... von V Mosienko · · Zitiert von: 124 — Daniel Beis a , Massimo Pasqualetti b , Jonas Waider c , Susann Matthes a , Fatimunnisa Qadri a , Michael Bader a , Natalia Alenina a. Show more. Add to ...
Depletion of angiotensin-converting enzyme 2 reduces ...Springer
link.springer.com
von F Klempin · · Zitiert von: 76 — Friederike Klempin, Valentina Mosienko, Susann Matthes, Mihail Todiras, Michael Bader & Natalia Alenina. Charité, University Medicine Berlin ... von F Klempin · · Zitiert von: 76 — Friederike Klempin, Valentina Mosienko, Susann Matthes, Mihail Todiras, Michael Bader & Natalia Alenina. Charité, University Medicine Berlin ...
Design of chemical libraries with potentially bioactive ...Springer
link.springer.com
von M Lisurek · · Zitiert von: 86 — The screening data were provided by Jörn Saupe, Samuel Beligny, Svantje Behnken and Susann Matthes. Three institutes, namely the Helmholtz ... von M Lisurek · · Zitiert von: 86 — The screening data were provided by Jörn Saupe, Samuel Beligny, Svantje Behnken and Susann Matthes. Three institutes, namely the Helmholtz ...
Alle Infos zum Namen "Susann Matthes"
Adaptive changes in serotonin metabolism preserve ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von V Mosienko · · Zitiert von: 36 — Authors. Valentina Mosienko , Susann Matthes , Natalie Hirth , Daniel Beis , Michael Flinders , Michael Bader , Anita C Hansson , Natalia Alenina ... von V Mosienko · · Zitiert von: 36 — Authors. Valentina Mosienko , Susann Matthes , Natalie Hirth , Daniel Beis , Michael Flinders , Michael Bader , Anita C Hansson , Natalia Alenina ...
Community-Wide Experimental Evaluation of the PROSS ...Europe PMC
europepmc.org
von Y Peleg · · Zitiert von: 41 — ... Susann Matthes. 9Max-Delbrück Center for Molecular Medicine (MDC)Berlin-Buch, Germany. Find articles by Susann Matthes ... von Y Peleg · · Zitiert von: 41 — ... Susann Matthes. 9Max-Delbrück Center for Molecular Medicine (MDC)Berlin-Buch, Germany. Find articles by Susann Matthes ...
Reply to Lrp5 regulation of bone mass and gut serotonin ...Gale
go.gale.com
von Y Cui · · Zitiert von: 28 — Author(s): Yajun Cui 1 , Paul J Niziolek 2 , Bryan T MacDonald 1 , Natalia Alenina 3 , Susann Matthes 3 , Christina M Jacobsen 1 , Ronald A Conlon von Y Cui · · Zitiert von: 28 — Author(s): Yajun Cui 1 , Paul J Niziolek 2 , Bryan T MacDonald 1 , Natalia Alenina 3 , Susann Matthes 3 , Christina M Jacobsen 1 , Ronald A Conlon
Tryptophan Hydroxylase as Novel Target for the Treatment ...Karger Publishers
karger.com
von S Matthes · · Zitiert von: 92 — Tryptophan Hydroxylase as Novel Target for the Treatment of Depressive Disorders. Subject Area: Pharmacology. Susann Matthes;. Susann Matthes. von S Matthes · · Zitiert von: 92 — Tryptophan Hydroxylase as Novel Target for the Treatment of Depressive Disorders. Subject Area: Pharmacology. Susann Matthes;. Susann Matthes.
Tryptophan hydroxylase as novel target for the treatment ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von S Matthes · · Zitiert von: 92 — Authors. Susann Matthes , Valentina Mosienko, Saleh Bashammakh, Natalia Alenina, Michael Bader. Affiliation. 1 Max Delbrück Center for Molecular Medicine ... von S Matthes · · Zitiert von: 92 — Authors. Susann Matthes , Valentina Mosienko, Saleh Bashammakh, Natalia Alenina, Michael Bader. Affiliation. 1 Max Delbrück Center for Molecular Medicine ...
sortiert nach Relevanz / Datum